Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams.
Innovation Excellence is a unique application of lean kaizen methodologies and personal coaching. It frees up capacity for innovative research, fosters ownership and significantly enhances the output of your research and innovation teams. It has the goal to improve current work processes in research and development but also life cycle management to increase efficiency. Together with ICH Q8 elements like Quality by Design, Innovation Excellence has to be seen as an overarching paradigm and an interdisciplinary approach across the product development lifecycle. It also systematically emphasises enhanced product throughout the product lifecycle.
Applying a management style that focuses on the process of learning, the art of continuous and scientific research can create a physical as well as a social environment where innovation can flourish.
The Workshop Innovation Excellence , which is also supported by an FDA speaker, will apply continuous improvement tools to help you gain the right knowledge. It will therefore give you a fresh view on how to make your research and development more efficient, faster and customer focused. For that purpose the training is filled with real life examples and exercises on how to:
To provide you the maximum benefit the Workshop is a mix of theoretic foundation and exercises.
For further information please see www.gmp-compliance.org/innovation.
Contact:
European Compliance Academy (ECA)
www.gmp-compliance.orginfo@gmp-compliance.org
Event date: October 30, 2012 - October 31, 2012, Berlin, Germany
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.